AAAAAA

   
Results: 1-11 |
Results: 11
IMMUNE-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INDUCEDBY CANARYPOX EXPRESSING HIV-1(MN) GP120, HIV-1(SF2) RECOMBINANT GP120, OR BOTH VACCINES IN SERONEGATIVE ADULTS
Authors: CLEMENTSMANN ML WEINHOLD K MATTHEWS TJ GRAHAM BS GORSE GJ KEEFER MC MCELRATH MJ HSIEH RH MESTECKY J ZOLLAPAZNER S MASCOLA J SCHWARTZ D SILICIANO R COREY L WRIGHT PF BELSHE R DOLIN R JACKSON S XU S FAST P WALKER MC STABLEIN D EXCLER JL TARTAGLIA J DULIEGE AM SINANGIL F PAOLETTI E
Citation: Ml. Clementsmann et al., IMMUNE-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INDUCEDBY CANARYPOX EXPRESSING HIV-1(MN) GP120, HIV-1(SF2) RECOMBINANT GP120, OR BOTH VACCINES IN SERONEGATIVE ADULTS, The Journal of infectious diseases, 177(5), 1998, pp. 1230-1246
NEUTRALIZATION OF A CLADE-B PRIMARY ISOLATE BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS-UNINFECTED RECIPIENTS OF CANDIDATE AIDS VACCINES
Authors: ZOLLAPAZNER S ALVING C BELSHE R BERMAN P BURDA S CHIGURUPATI P CLEMENTS ML DULIEGE AM EXCLER JL HIOE C KAHN J MCELRATH MJ SHARPE S SINANGIL F STEIMER K WALKER MC WASSEF N XU S
Citation: S. Zollapazner et al., NEUTRALIZATION OF A CLADE-B PRIMARY ISOLATE BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS-UNINFECTED RECIPIENTS OF CANDIDATE AIDS VACCINES, The Journal of infectious diseases, 175(4), 1997, pp. 764-774
PHASE-I PHASE-II PREVENTIVE VACCINE TRIALS - CONFERENCE SUMMARY
Authors: WALKER MC FAST PE GRAHAM BS BELSHE R DOLIN R
Citation: Mc. Walker et al., PHASE-I PHASE-II PREVENTIVE VACCINE TRIALS - CONFERENCE SUMMARY, AIDS research and human retroviruses, 11(10), 1995, pp. 1279-1285
SAFETY PROFILE OF HIV VACCINATION - FIRST 1000 VOLUNTEERS OF AIDS VACCINE EVALUATION GROUP
Authors: KEEFER MC BELSHE R GRAHAM B MCELRATH J CLEMENTS ML SPOSTO R FAST P
Citation: Mc. Keefer et al., SAFETY PROFILE OF HIV VACCINATION - FIRST 1000 VOLUNTEERS OF AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 10, 1994, pp. 190000139-190000140
EXPANDED SAFETY AND IMMUNOGENICITY TRIAL OF RECOMBINANT GP120 VACCINES VOLUNTEERS (AVEG PROTOCOL-201)
Authors: MCELRATH MJ COREY L CLEMENTS ML BELSHE R KEEFER M GRAHAM B SPOSTO R FAST P
Citation: Mj. Mcelrath et al., EXPANDED SAFETY AND IMMUNOGENICITY TRIAL OF RECOMBINANT GP120 VACCINES VOLUNTEERS (AVEG PROTOCOL-201), AIDS research and human retroviruses, 10, 1994, pp. 190000155-190000155
ANALYSIS OF THE IMMUNOGENICITY OF RECOMBINANT GP120
Authors: BERMAN PW NAKAMURA GR HASTINGS R WILKES D FOX J BYRN R SCHWARTZ D BELSHE R MATTHEWS T NORCROSS MA
Citation: Pw. Berman et al., ANALYSIS OF THE IMMUNOGENICITY OF RECOMBINANT GP120, AIDS research and human retroviruses, 10, 1994, pp. 190000046-190000046
COMPARISON OF THE IMMUNE-RESPONSE TO RECOMBINANT GP120 IN HUMANS AND CHIMPANZEES
Authors: BERMAN PW EASTMAN DJ WILKES DM NAKAMURA GR GREGORY TJ SCHWARTZ D GORSE G BELSHE R CLEMENTS ML BYRN RA
Citation: Pw. Berman et al., COMPARISON OF THE IMMUNE-RESPONSE TO RECOMBINANT GP120 IN HUMANS AND CHIMPANZEES, AIDS, 8(5), 1994, pp. 591-601
IMMUNOLOGICAL RESPONSES IN HIV-SERONEGATIVE VOLUNTEERS TO LIVE RECOMBINANT AND SUBUNIT HIV-1 ENVELOPE VACCINES
Authors: CLEMENTS ML GRAHAM B BELSHE R DOLIN R COREY L FAST P STABLEIN D SILICIANO R BOLOGNESI D WRIGHT P GORSE G KEEFER M SCHWARTZ D MCELRATH J MATTHEWS T
Citation: Ml. Clements et al., IMMUNOLOGICAL RESPONSES IN HIV-SERONEGATIVE VOLUNTEERS TO LIVE RECOMBINANT AND SUBUNIT HIV-1 ENVELOPE VACCINES, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 682-682
SAFETY AND IMMUNOGENICITY OF GENENTECH-IIIB RGP 120 HIV-1/
Authors: SCHWARTZ D CLEMENTS ML HOPKINS J BERMAN P DULIEGE AM TWADELL T AMMANN A BELSHE R GORSE G MATTHEWS T BOLOGNESI D FAST P SPOSTO R STABLEIN D
Citation: D. Schwartz et al., SAFETY AND IMMUNOGENICITY OF GENENTECH-IIIB RGP 120 HIV-1/, AIDS research and human retroviruses, 9, 1993, pp. 190000112-190000112
SAFETY AND IMMUNOGENICITY OF LAMBDA-BACULOVIRUS DERIVED HIV-1 IIIB RECOMBINANT GP160 VACCINE (VAXSYN(R)) IN HUMANS
Authors: KEEFER M BELSHE R CLEMENTS M GRAHAM B COREY L BOLOGNESI D STABLEIN D FAST P MONTEFIORI D SMITH G DOLIN R
Citation: M. Keefer et al., SAFETY AND IMMUNOGENICITY OF LAMBDA-BACULOVIRUS DERIVED HIV-1 IIIB RECOMBINANT GP160 VACCINE (VAXSYN(R)) IN HUMANS, AIDS research and human retroviruses, 9, 1993, pp. 190000113-190000113
INDUCTION OF HIV-1-NEUTRALIZING AND SYNCYTIUM-INHIBITING ANTIBODIES IN UNINFECTED RECIPIENTS OF HIV-1(IIIB) RGP120-SUBUNIT VACCINE
Authors: SCHWARTZ DH GORSE G CLEMENTS ML BELSHE R IZU A DULIEGE AM BERMAN P TWADDELL T STABLEIN D SPOSTO R SILICIANO R MATTHEWS T
Citation: Dh. Schwartz et al., INDUCTION OF HIV-1-NEUTRALIZING AND SYNCYTIUM-INHIBITING ANTIBODIES IN UNINFECTED RECIPIENTS OF HIV-1(IIIB) RGP120-SUBUNIT VACCINE, Lancet, 342(8863), 1993, pp. 69-73
Risultati: 1-11 |